Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gunther Birznieks
26 Aug 2022
SVP, Business Development
Exercised, kept
1,250
$3.12
$3.90K
Thomas Watkins
3 May 2018
Director
Exercised, kept
15,000
$4.98
$74.70K
Richard W Dugan
19 Mar 2018
Director
Exercised, kept
15,000
$4.98
$74.70K

What was left out

Form 4 filings counted 218
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 33
Sales at will 109
Transactions with no price 0
Shares from compensation/vesting 7,423,904
Sales filed before the plan box existed 84
History held since 3 Nov 2006